Dogwood Therapeutics, Inc. (DWTX) Live Share Price, Invest From India

Dogwood Therapeutics, Inc. Stock Performance

as on May 8, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.45
Day's Price Range
$1.68
$1.56
7.05%
Downside
7.69%
Upside
52 Week's Low
52 Week's High
$1.28
52-Week Price Range
$9.50
$1.56
17.95%
Downside
508.97%
Upside

Dogwood Therapeutics, Inc. share price movements today

Previous Close: $1.65
Open: $1.64
Volume: 459.9K
Day's Low - High: $1.45 - $1.68
52 Week Low - High: $1.28 - $9.50

Dogwood Therapeutics, Inc. Historical Returns

1 Month Return: -18.32 %
3 Month Return: -47.95 %
1 Year Return: -64.36 %
3 Year Return: 0 %
5 Year Return: 0 %

Dogwood Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Dogwood Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.1M

EPS (TTM)

-0.8567

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-49.23%

Dogwood Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dogwood Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Dogwood Therapeutics, Inc.	NA	$48.1M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Dogwood Therapeutics, Inc. Stock including INR - Dollar returns

The Dogwood Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Dogwood Therapeutics, Inc. investment value today

Current value as on today

₹37,479

Returns

-₹62,521

(-62.52%)

Returns from Dogwood Therapeutics, Inc. Stock

-₹66,307 (-66.31%)

Dollar Impact

₹3,785 (+3.79%)

Indian Investors' Interest in Dogwood Therapeutics, Inc. Stock

Search interest for Dogwood Therapeutics, Inc. Stock has increased by 75% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 8, 2026 to May 8, 2026

Change:75% versus previous 30 day period

Dogwood Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	0	0	0	-	-
Operating Income	-1	-1	-1	-1	-2	-7	-4	-3	-15	-3
EBITDA	-1	-1	-1	-1	-2	-7	-4	-3	-15	-3
Interest Expense	-	-	-	-	-	0	0	-	-	-
Depreciation	-	-	-	-	-	-	0	0	0	-
Income Before Tax	-1	-1	-1	-1	-2	-7	-10	-3	-15	-3
Income Tax Expense	-	-	-	-	-	0	0	0	0	0
Net Income	-1	-1	-1	-1	-2	-7	-10	-3	-15	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dogwood Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	-
Operating Income	-10	-15	-12	-5	-12	-27
EBITDA	-10	-15	-12	-5	-12	-27
Interest Expense	0	-	-	-	0	-
Depreciation	-	-	-	-	0	0
Income Before Tax	-10	-15	-12	-5	-12	-34
Income Tax Expense	-	-	-	-	0	0
Net Income	-10	-15	-12	-5	-12	-34
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dogwood Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	-1	-1	-2	-7	-10	-3	-15	-3
Operating Cash Flow	-1	0	0	0	-6	-4	-4	-3	-3
Investing Cash Flow	-	-	-	-	3	-	-	-	-
Financing Cash Flow	-	-	1	0	15	7	0	-	0
Change in Cash	-1	0	0	0	12	2	-4	-3	-3

Dogwood Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-10	-15	-12	-5	-12	-34
Operating Cash Flow	-2	-3	-15	-11	-4	-8	-15
Investing Cash Flow	-	-	-	-	-	3	-
Financing Cash Flow	2	33	0	4	1	16	7
Change in Cash	0	29	-15	-6	-3	11	-8

Insights on Dogwood Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, DWTX stock has moved up by 13.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 116.2%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 32.8% return, outperforming this stock by 96.6%

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.

Organisation	Dogwood Therapeutics, Inc.
Headquarters	44 Milton Avenue, Alpharetta, GA, United States, 30009
Industry	Biotechnology
CEO	Mr. Gregory Duncan
E-voting on shares	Click here to vote

Key Management of Dogwood Therapeutics, Inc.

Name	Title
Ms. Angela Walsh	CFO, Secretary & Treasurer
Dr. R. Michael Gendreau M.D., Ph.D.	Chief Medical Officer
Dr. William L. Pridgen M.D.	Founder & Member of Scientific Advisory Board
Mr. Ralph D. Grosswald M.P.H.	Senior Vice President of Operations
Ms. Carol Duffy Ph.D.	Chief Scientific Advisor
Mr. Gregory Duncan	Chairman & CEO

FAQs

What is Dogwood Therapeutics, Inc. share price today?

Dogwood Therapeutics, Inc. share price today is $1.56 as on May 8, 2026 at 8:45 am IST at the close of the market. Dogwood Therapeutics, Inc. share today touched a day high of $1.68 and a low of $1.45.

What is the 52 week high and 52 week low for Dogwood Therapeutics, Inc. share?

Dogwood Therapeutics, Inc. share touched a 52 week high of $9.5 on September 29, 2025 and a 52 week low of $1.28 on April 29, 2026. Dogwood Therapeutics, Inc. stock price today i.e. May 8, 2026 at 8:45 am IST is closed at $1.56,which is 83.58% down from its 52 week high and 21.88% up from its 52 week low.

What is Dogwood Therapeutics, Inc.'s market capitalisation today?

Dogwood Therapeutics, Inc. market capitalisation is $0.00T as on May 8, 2026 at 8:45 am IST.

How to invest in Dogwood Therapeutics, Inc. Stock (DWTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dogwood Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dogwood Therapeutics, Inc. Shares that will get you 0.9615 shares as per Dogwood Therapeutics, Inc. share price of $1.56 per share as on May 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy Dogwood Therapeutics, Inc. Stock (DWTX) from India?

Indian investors can start investing in Dogwood Therapeutics, Inc. (DWTX) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 10:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Dogwood Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 10:41 am IST). Based on Dogwood Therapeutics, Inc. share’s latest price of $1.56 as on May 8, 2026 at 8:45 am IST, you will get 6.4103 shares of Dogwood Therapeutics, Inc.. Learn more about fractional shares .